@entity2071 ( @entity2071 ) and @entity4105 and other variables were evaluated as possible markers of the success of multidrug therapy (MDT) in @entity1201 . @entity1202 ( @entity1202 , N = 45) and paucibacillary (PB, N = 29) @entity1201 @entity1 were examined during MDT, which typically lasted 12 months for @entity1202 and 6 months for PB patients. Serum values for total protein, albumin, immunoglobulin gamma (IgG), @entity2071 , and @entity4105 (selectin) were recorded, as were lesion type, number, and distribution. Response at the end of therapy was assessed as good, fair, or poor. The bacterial index (BI) of lesions was measured at the beginning and end of therapy. The earlier reported findings of this investigation are herein re-examined. RESULTS: age and lowered serum albumin correlated with the poorer condition of the @entity1 , as did elevated selectin. Albumin was inversely correlated with the BI (p = 0.008) in @entity1202 patients, and IgG was positively correlated (p = 0.009). ICAM and @entity4105 alone were not useful markers of individual @entity1 condition. A regression combining serum albumin under 41 g/l, age and @entity4105 was able to identify 85% of the @entity1 in poorer condition. CONCLUSION: serum albumin was a useful nonspecific marker of both @entity1 condition and @entity281 . Age is an important negative factor in @entity1 response. Albumin and IgG correlate with the BI and with each other (p = 0.011) in @entity1202 @entity1 , but not in PB @entity1 .

Serum markers of treatment success in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity4105 :: ('6401', 'Gene') :: ['E-selectin'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity1202 :: ('MESH:D056006', 'Disease') :: ['MB', 'Multibacillary'] @entity2071 :: ('3383', 'Gene') :: ['ICAM-1', 'Intercellular adhesion molecule-1'] @entity1201 :: ('MESH:D007918', 'Disease') :: ['leprosy']
@entity1201 :: (MESH:D007918,Disease) :: ['leprosy']
